Ignite Creation Date:
2024-07-17 @ 11:15 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499194
Status:
COMPLETED
Last Update Posted:
2024-07-12
First Post:
2024-07-06
Brief Title:
Health Expenses and Outcomes of the DASH Diet in Egyptian Patients With Hypertension
Sponsor:
Beni-Suef University
Organization:
Beni-Suef University
Study Overview
Official Title:
Health Expenses and Outcomes of the DASH Diet in Egyptian Patients With Hypertension
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
DASH diet can reduce hypertension and decrease health expenses
Detailed Description:
Hypertension is a prevalent cardiovascular risk factor associated with adverse outcomes and obesity Egypts prevalence is 263 exceeding rates in the US and sub-Saharan Africa Lifestyle interventions like the DASH diet effectively manage hypertension offering a cost-effective alternative to pharmacological treatments This study aims to assess the effects of the DASH diet on blood pressure BMI waist circumference and fasting blood glucose as well as its cost-effectiveness compared to pharmacological treatments This open-label prospective controlled clinical trial was conducted in Esna Health Administration Luxor Governorate The FMREC of Beni-Suef University approved the study which included 364 hypertensive patients aged 30-60 Exclusions were patients with severe comorbidities or those who declined participation Measurements included height weight BMI blood pressure and laboratory tests The intervention group received a DASH diet education program Outcomes measured were blood pressure BMI waist circumference weight and fasting blood glucose at baseline and post-intervention Our study demonstrates the significant benefits of the DASH diet in managing blood pressure weight and fasting blood glucose levels in the Egyptian population The DASH diet substantially reduced systolic and diastolic blood pressure with a notable decrease in the number of antihypertensive medications needed Additionally participants on the DASH diet experienced significant weight loss and reduced BMI and waist circumference compared to the control group The economic implications of the DASH diet are also promising with a notable decrease in the total cost of therapy due to reduced medication costs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None